Preparation of Immunotoxin Herceptin-Botulinum and Killing Effects on Two Breast Cancer Cell Lines.

Saieh Hajighasemlou,M Alebouyeh,Hossein Rastegar, Mojgan Taghizadeh Manzari,Milad Mirmoghtadaei,Behjat Moayedi, Maryam Ahmadzadeh,Farzad Parvizpour,B Johari, M M Naeini,Mohammadmorad Farajollahi

Asian Pacific journal of cancer prevention : APJCP（2015）

引用 37|浏览14

暂无评分

摘要

Toxin-Herceptin bioconjugation can be a potential candidate with increased efficiency for treating breast cancer patients with over expression of the HER2 receptor.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要